Monitoring of antiplatelet therapy with the PFA-100® in peripheral angioplasty patients

Platelets

Volumn 13, Issue 8, 2002, Pages 493-497

  Ziegler, S ^a,b   Maca, T ^a   Alt, E ^a   Speiser, W ^b   Schneider, B ^b   Minar, E ^a  

^a University School of Medicine   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; THIENO[2,3 B]PYRIDINE DERIVATIVE; CLOPIDOGREL; DRUG DERIVATIVE; TICLOPIDINE;

AGED; ANGIOPLASTY; ARTICLE; CARDIOVASCULAR RISK; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RESTENOSIS; THROMBOCYTE FUNCTION; BLOOD; CORONARY ARTERY DISEASE; DRUG MONITORING; INSTRUMENTATION; PHYSIOLOGY; THROMBOCYTE; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, BALLOON; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ARTERIAL OCCLUSIVE DISEASES; BLOOD PLATELETS; CORONARY DISEASE; CORONARY RESTENOSIS; DRUG MONITORING; FEMALE; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE;

EID: 0036890868     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/0953710021000057866     Document Type: Article

References (27)

1. Roller RE, Janisch S, Kvas E, Schnedl WJ, Binder BR, Wojta J, Korninger C. Smooth muscle cell migration promoting activity of plasma predicts restenosis in patients with peripheral arterial occlusive disease undergoing angioplasty. Thromb Haemost 2000; 84(6): 1113-16.
2. Steele PM, Chesebro JH, Stanson AW. Balloon angioplasty: Natural history of the pathophysiological response to injury in a pig model. Circ Res 1985; 57: 105-12.
3. Lam JYT, Chesebro JH, Steele PM, Badimon L, Fuster V. Is vasospasm related to platelet deposition? Relationship in a porcine preparation of arterial injury in vivo. Circulation 1987; 75: 243-8.
4. Minar E, Ahmadi A, Koppensteiner R, Maca T, Stümpflen A, Ugurluoglu A, Ehringer H. Comparison of effects of high-dose and low-dose aspirin on restenosis after femoropopliteal percutaneous transluminal angioplasty. Circulation 1995; 91(8): 2167-73.
5. Mueller MR, Salat A, Stangl P, Murabido M, Pulaki S, Boehm D, Koppensteiner R, Ergun E, Mittlbök M, Schreiner W, Losert U, Wolner E. Variable platelet response to low dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty. Thromb Haemost 1997; 78: 1003-7.
6. Homoncik M, Jilma B, Hergovich N, Stohlawetz P, Panzer S, Speiser W. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100®. Thromb Haemost 2000; 83: 316-21.
7. Buchanan M, Brister S. Individual variation in the effects of ASA on platelet function: Implication for the use of ASA clinically. Can J Cardiol 1995; 11(3): 221-7.
8. Beving H, Eksborg S, Malmgren RS, Nordlander R, Ryden L, Olsson P. Inter-individual variations of the effect of low dose aspirin regime on platelet cyclooxygenase activity. Thromb Res 1994; 74(1): 39-51.
9. Benedek IHB, Joshi AS, Pieniaszek HJ, King SYP, Kornhauser DM. Variability in the pharmacokinetics and pharmacodynamics of low dose aspirin in healthy male volunteers. J Clin Pharmacol 1995; 35: 1181-6.
10. Kottke-Marchant K, Powers JB, Brooks L, Kundu S, Christie DJ. The effect of antiplatelet drugs, heparin and preanalytical variables on platelet function detected by the platelet function analyzer (PFA-100). Clin Appl Thromb Hemost 1999; 5(2): 122-30.
11. Dalby MC, Davidson SJ, Burman JF, Davies SW. Diurnal variation in platelet aggregation with the PFA-100 platelet function analyzer. Platelets 2000; 11(6): 320-4.
12. Moeller A, Weippert-Kretschmer M, Prinz H, Kretschmer V. Influence of ABO blood groups on primary hemostasis. Transfusion 2001; 41: 56-60.
13. Theroux P, Ouimet H, McCans J, Latour JG, Joly P, Levy G, Pelletier E, Juneau M, Stasiak J, de Guise P. Aspirin, heparin, or both to treat acute unstable angina. New Engl J Meal 1988; 319: 1105-11.
14. Terres W, Hamm CW, Ruchelka A, Weilepp A, Kupper W. Residual platelet function under acetylsalicylic acid and the risk of restenosis after coronary angioplasty. J Cardiovasc Pharmacol 1992; 19: 190-3.
15. Mc Kenzie ME, Gurbel PA, Levine DJ, Serebrunay VL. Clinical utility of available methods for determining platelet function. Cardiology 1999; 92: 240-7.
16. Kundu SK, Heilmann EJ, Sio R, Garcia C, Davidson RM, Ostgaard RA. Description of an in vitro platelet function analyzer-PFA-100. Semin Thromb Hemost 1995; 21(Suppl 2): 106-12.
17. Ortel TL, Andra H, Thames EH, Karen DM, Moore KD, Greenberg CS. Assessment of primary hemostasis by PFA-100®. Analysis in a tertiary care center. Thromb Haernost 2000; 84: 93-7.
18. Sestito A, Sciahbasi A, Landolfi R, Maseri A, Lanza GA, Andreotti F. A simple assay for platelet-mediated hemostasis in flowing whole blood (PFA-100): Reproducibility and effects of sex and age. Cardiologia 1999; 44(7): 661-5.
19. Boeck M, Haan JD, Beck KH, Gutensohn K, Hertfelder HJ, Karger R, Helm MU, Beesh H, Weber D, Kretschmer V. Standardization of the PFA-100® platelet function test in 105mmol/l buffered citrate: Effect of gender, smoking and oral contraceptives. Br J Haematol 1999; 106: 898-904.
20. Heilmann EJ, Kundu SK, Sio R, Garcia C, Gomez R, Christie DJ. Comparison of four commercial citrate blood collection systems for platelet function analysis by the PFA-100 system. Thromb Res 1997; 87: 159-64.
21. Marshall PW, Williams RM, Growcott DJW, Warburton S, Armstrong J, Moores J. A comparison of the effects of aspirin on bleeding time measured using the simplate method and closure time measured using the PFA-100, in healthy volunteers. Br J Clin Pharmacol 1997; 44: 151-5.
22. Fischetti D, Sciahbasi A, Leone AM, Niccoli G, Schiavoni G, Trani C, Mazzari MA, Andreotti F. Ticlopidine and aspirin fail to suppress the increased platelet aggregability that follows percutaneous coronary interventions. J Thromb Thrombolys 2000; 10(3): 265-9.
23. Mammen EF, Comp PC, Gosselin R, Greenberg C, Hoots WK, Kessler O, Larkin EC, Liles D, Nugent DJ. PFA-100: A new method for assessment of platelet dysfunction. Semin Thromb Hemost 1998; 24(2): 195-202.
24. Grotemeyer KH, Schrafinski HW, Husstedt IW. Two year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients. Thromb Res 1993; 71: 397-403.
25. Grotemeyer KH. Effects of acetylsalicylic acid in stroke patients; evidence of nonresponders in a subpopulation of treated patients. Thromb Res 1991; 63: 587-93.
26. Nakamura T, Ariyoshi H, Kambayashi J, Ikeda M, Shinoki N, Kawasaki T, Monden M. Signal transduction system in epinephrine stimulated platelets; comparison between epinephrine sensitive and insensitive platelets. Thromb Res 1997; 85: 83-93.
27. Favalore EJ. Utility of the PFA-100® for assessing bleeding disorders and monitoring therapy: A review of analytical variables, benefits and limitations. Haemophilia 2001; 7(2): 170-9.